HOPE-BP 2.0 Study Comparing 2-Week vs. 6-Week Postpartum Remote Blood Pressure Monitoring for Women with Hypertensive Disorders After Pregnancy

What this Trial Is About

Researchers are studying the best length of time for postpartum remote blood pressure monitoring in patients who had hypertensive disorders during pregnancy. This study aims to find out how different program durations affect clinical outcomes in patients enrolled in a postpartum remote monitoring program at a single institution. There has been no prior evaluation to determine whether a 2-week or 6-week monitoring program is more beneficial. Participants are randomly assigned to one of two groups a 2-week monitoring group or a 6-week monitoring group. Those in the 2-week group will stop the remote monitoring after 2 weeks and return to standard postpartum care, while those in the 6-week group will complete the full 6-week monitoring program. The program requires patients to submit blood pressure readings twice daily via a digital platform, which are reviewed by a dedicated nursing team who may adjust medications as needed. During the study, participants will be monitored for blood pressure outcomes at 6 weeks postpartum, including diastolic and systolic blood pressure, rates of severe hypertension, and new hypertension diagnoses. The study also tracks follow-up visit attendance, unscheduled medical visits, and patient satisfaction surveys. The total participation duration depends on the assigned program length, with clinical data collected to assess the impact of monitoring duration on health outcomes.

HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring